These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17691773)

  • 21. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes.
    Gazi L; Gyles S; Rose J; Lees S; Allan C; Xue L; Jassal R; Speight G; Gamble V; Pettipher R
    Prostaglandins Other Lipid Mediat; 2005 Jan; 75(1-4):153-67. PubMed ID: 15789622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor.
    Monneret G; Gravel S; Diamond M; Rokach J; Powell WS
    Blood; 2001 Sep; 98(6):1942-8. PubMed ID: 11535533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
    Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand.
    Sharif NA; Williams GW; Davis TL
    Br J Pharmacol; 2000 Nov; 131(6):1025-38. PubMed ID: 11082108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?
    Rangachari PK; Betti PA; Prior ET; Roberts LJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):611-7. PubMed ID: 7473146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of chimeric prostacyclin/prostaglandin D(2) receptors.
    Wise H
    Eur J Pharmacol; 1999 Dec; 386(1):89-96. PubMed ID: 10611468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First principles predictions of the structure and function of g-protein-coupled receptors: validation for bovine rhodopsin.
    Trabanino RJ; Hall SE; Vaidehi N; Floriano WB; Kam VW; Goddard WA
    Biophys J; 2004 Apr; 86(4):1904-21. PubMed ID: 15041637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
    Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
    Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an indole series of prostaglandin D2 receptor antagonists.
    Sturino CF; Lachance N; Boyd M; Berthelette C; Labelle M; Li L; Roy B; Scheigetz J; Tsou N; Brideau C; Cauchon E; Carriere MC; Denis D; Greig G; Kargman S; Lamontagne S; Mathieu MC; Sawyer N; Slipetz D; O'Neill G; Wang Z; Zamboni R; Metters KM; Young RN
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3043-8. PubMed ID: 16529930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposing roles of prostaglandin D2 receptors in ulcerative colitis.
    Sturm EM; Radnai B; Jandl K; Stančić A; Parzmair GP; Högenauer C; Kump P; Wenzl H; Petritsch W; Pieber TR; Schuligoi R; Marsche G; Ferreirós N; Heinemann A; Schicho R
    J Immunol; 2014 Jul; 193(2):827-39. PubMed ID: 24929001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist.
    Wright DH; Metters KM; Abramovitz M; Ford-Hutchinson AW
    Br J Pharmacol; 1998 Apr; 123(7):1317-24. PubMed ID: 9579725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DP(2) receptor antagonists in development.
    Norman P
    Expert Opin Investig Drugs; 2010 Aug; 19(8):947-61. PubMed ID: 20615077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils.
    Cossette C; Walsh SE; Kim S; Lee GJ; Lawson JA; Bellone S; Rokach J; Powell WS
    J Pharmacol Exp Ther; 2007 Jan; 320(1):173-9. PubMed ID: 17041009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin D₂ induces contractions through activation of TP receptors in peripheral lung tissue from the guinea pig.
    Larsson AK; Hagfjärd A; Dahlén SE; Adner M
    Eur J Pharmacol; 2011 Nov; 669(1-3):136-42. PubMed ID: 21872585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptin Elicits LTC
    Amorim NRT; Luna-Gomes T; Gama-Almeida M; Souza-Almeida G; Canetti C; Diaz BL; Weller PF; Torres Bozza P; Maya-Monteiro CM; Bandeira-Melo C
    Front Immunol; 2018; 9():2139. PubMed ID: 30298073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells.
    Chan CL; Jones RL; Lau HY
    Br J Pharmacol; 2000 Feb; 129(3):589-97. PubMed ID: 10711359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway.
    Kobayashi K; Tsubosaka Y; Hori M; Narumiya S; Ozaki H; Murata T
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):565-71. PubMed ID: 23307871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells.
    Oyama S; Fujino H; Yamazaki R; Okura I; Regan JW; Awata A; Arai T; Murayama T
    Arch Biochem Biophys; 2014 Jan; 541():21-9. PubMed ID: 24239863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
    Shahbazian A; Heinemann A; Peskar BA; Holzer P
    Br J Pharmacol; 2002 Dec; 137(7):1047-54. PubMed ID: 12429577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differential functional coupling of phosphodiesterase 4 to human DP and EP2 prostanoid receptors stimulated with PGD
    Okura I; Hasuoka N; Senoo K; Suganami A; Fukushima K; Regan JW; Mashimo M; Murayama T; Tamura Y; Fujino H
    Pharmacol Rep; 2021 Jun; 73(3):946-953. PubMed ID: 33786738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.